CancerLinQ™ Platform Hits Milestone of Having More than One Million Patient Records in System

Seventy Practices Have Signed Agreements to Participate
For immediate release
October 20, 2016

Contact

Aaron Tallent
(571) 483-1371

ALEXANDRIA, Va. – CancerLinQ LLC, a wholly-owned nonprofit of the American Society of Clinical Oncology (ASCO), announced today that more than one million patient records are now in the CancerLinQ™ platform. In addition, 70 practices have signed agreements to participate in CancerLinQ, representing more than 1,500 oncologists.

“We are excited to reach this milestone and continue to be awed and inspired by the engagement and support from the oncology community,” said CancerLinQ LLC CEO Kevin Fitzpatrick. “As more records enter the CancerLinQ platform, it will enhance participating oncologists’ ability to improve the quality of care that they provide.”

CancerLinQ™ is a powerful platform containing growing amounts of real-world cancer information. This national initiative will allow cancer providers to improve the quality and value of care by analyzing millions of cancer patient medical records, uncovering patterns and trends, and measuring their care against that of their peers and recommended guidelines. The CLQ platform was co-developed with SAP utilizing the SAP Connected Health platform that runs on SAP HANA, a flexible, in-memory data management and application platform created by SAP.

CancerLinQ LLC has completed agreements with 70 oncology practices in 39 states and the District of Columbia, and is potentially available to any practice nationwide. Participants range from small private practices to some of the nation’s leading cancer centers. CancerLinQ has also successfully connected with most major EHR systems, including both enterprise and oncology-specific systems, showing data can be shared seamlessly and securely across technical platforms. To view the list of practices participating in CancerLinQ™, please go to http://cancerlinq.org/care-team.

CancerLinQ™ is supported in part through the Conquer Cancer Foundation, whose generous donors have helped make the system possible. Major supporters include Amgen; Astellas; AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Cancer Treatment Centers of America®; Chan Soon-Shiong Family Foundation; Genentech BioOncology™; HELSINN; Janssen Oncology; Lilly; Novartis Oncology; Pfizer Oncology; Raj Mantena, RPh; Susan G. Komen®; and Thomas G. Roberts, Jr., MD, and Susan M. DaSilva.

CancerLinQ™ is a project of CancerLinQ LLC. For more information, please visit CancerLinQ.org.

About ASCO: 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.

About CancerLinQ LLC

CancerLinQ LLC is a subsidiary of American Society of Clinical Oncology, Inc. established for the development and operation of the CancerLinQ™ initiative. CancerLinQ™ is a health information technology platform aimed at enhancing and improving the understanding and treatment of cancer. To learn more, visit www.cancerlinq.org.